| 000 | 01322 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516234815.0 | ||
| 264 | 0 | _c20170412 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1872-7913 | ||
| 024 | 7 |
_a10.1016/j.ijantimicag.2014.07.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDutta, Noton K | |
| 245 | 0 | 0 |
_aPA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cDec 2014 |
||
| 300 |
_a564-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 |
_aLatent Tuberculosis _xdrug therapy |
| 650 | 0 | 4 |
_aLung _xmicrobiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 |
_aNitroimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 700 | 1 | _aKarakousis, Petros C | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 44 _gno. 6 _gp. 564-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijantimicag.2014.07.012 _zAvailable from publisher's website |
| 999 |
_c24236637 _d24236637 |
||